Free Trial
OTCMKTS:MEDOF

Medios (MEDOF) Stock Price, News & Analysis

Medios logo
C$13.64 0.00 (0.00%)
As of 11/6/2026

About Medios Stock (OTCMKTS:MEDOF)

Advanced

Key Stats

Today's Range
C$13.64
▼
C$13.64
50-Day Range
C$13.64
▼
C$13.64
52-Week Range
C$13.64
▼
C$13.64
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Medios AG is a Germany-based specialty pharmaceutical company that supplies medicines and services for patients with complex or rare conditions. Its work supports therapies in areas such as oncology, neurology and autoimmune diseases, where treatment may require specialized medicines or preparation for an individual patient.

The company distributes specialty medicines to pharmacies and other healthcare providers and prepares patient-specific therapies, including sterile infusions and other compounded medicines. It also provides services to pharmacies involved in delivering specialized treatments.

Founded in 2016 and headquartered in Berlin, Medios primarily serves the German market and has expanded its European activities, including through its acquisition of the Dutch specialty-pharmacy group Ceban. Its operations combine pharmaceutical distribution, individualized therapy preparation and related pharmacy services.

AI Generated. May Contain Errors.

Receive MEDOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medios and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MEDOF Stock News Headlines

See More Headlines

MEDOF Stock Analysis - Frequently Asked Questions

Medios' stock was trading at C$13.64 on January 1st, 2026. Since then, MEDOF stock has increased by 0.0% and is now trading at C$13.64.

Shares of MEDOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:MEDOF
CIK
N/A
Fax
N/A
Employees
993
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (OTCMKTS:MEDOF) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners